Target intelligence / Profile preview

Dopamine receptor D5 subtype (D5R)

Target
D5R
Molecular classification
G protein-coupled receptor (GPCR), Receptor
01

Overview

Dopamine receptor D5 subtype (D5R) is a G protein-coupled receptor of the D1-like dopamine receptor family, encoded by the DRD5 gene in humans[1][2]. D5R has roughly 10-fold higher affinity for dopamine compared to the D1 receptor[1]. Upon activation, D5R stimulates adenylyl cyclase, leading to increased intracellular cAMP through Gαs/olf protein coupling[1][2]. D5R is highly expressed in cortical brain regions and plays a critical role in regulating learning and memory, neuronal oscillatory activity, and cognitive processes[4]. Dysfunction or altered signaling through D5R is implicated in cognitive impairment and potentially other neuropsychiatric conditions[4]. Pharmacological targeting of D5R may modulate brain-derived neurotrophic factor and protein kinase B signaling[1][4]. Few ligands distinguish D5R reliably from D1R due to their close homology, making highly selective drugs difficult to develop[1][4].

Other names
Dopamine D5 receptorDRD5 (gene name)D1BR
02

Mechanism of action

Agonists mimic dopamine action, activating the receptor, promoting cAMP synthesis via Gαs/olf signaling. Antagonists/inverse agonists block receptor activation or induce opposite signaling effects.

03

Biological functions

Signal transduction via dopamineActivation of adenylyl cyclase and cAMP synthesisRegulation of neuronal oscillatory activityModulation of learning and memoryPromotion of brain-derived neurotrophic factor expressionRegulation of phosphorylation of protein kinase B
04

Disease associations

Neuropsychiatric disordersCognitive dysfunction and memory disordersPossible involvement in neurodegenerative diseases (as related to cognitive decline)Potential role in cardiovascular function (expression in heart and kidney; less established)
05

Safety considerations

D5R antagonists/agonists may impact CNS function, including memory, cognition, and moodHigh sequence homology with D1R complicates pharmacological selectivity, increasing risk of off-target effectsKnockdown of D5R affects neuronal oscillatory activity, which can lead to cognitive deficitsThere may be sex-dependent variations in D5R function and drug response
06

Interacting drugs

Dihydrexidine

7 more in the full profile.

07

Biomarkers

No widely accepted clinical biomarkers specific for D5R currently, although GSK-3β activity downstream of D5R may represent a candidate for research in cognitive disorders

Beyond the preview

Go deeper on Dopamine receptor D5 subtype (D5R).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Dopamine receptor D5 subtype (D5R).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call